相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Frequency of the TP53 R337H variant in sporadic breast cancer and its impact on genomic instability
Carolina Mathias et al.
SCIENTIFIC REPORTS (2020)
Current review of TP53 pathogenic germline variants in breast cancer patients outside Li-Fraumeni syndrome
Cristina Fortuno et al.
HUMAN MUTATION (2018)
Clinical implications of germline mutations in breast cancer: TP53
Katherine Schon et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families
Patricia Llovet et al.
FAMILIAL CANCER (2017)
Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families
Jun Li et al.
JOURNAL OF MEDICAL GENETICS (2016)
Risks of First and Subsequent Cancers Among TP53 Mutation Carriers in the National Cancer Institute Li-Fraumeni Syndrome Cohort
Phuong L. Mai et al.
CANCER (2016)
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
Gaelle Bougeard et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients
Felipe C. Silva et al.
BMC MEDICAL GENETICS (2014)
Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil
Juliana Giacomazzi et al.
PLOS ONE (2014)
Impact of Neonatal Screening and Surveillance for the TP53 R337H Mutation on Early Detection of Childhood Adrenocortical Tumors
Gislaine Custodio et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Hereditary Breast Cancer: The Era of New Susceptibility Genes
Paraskevi Apostolou et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Early onset HER2-positive breast cancer is associated with germline TP53 mutations
Amal Melhem-Bertrandt et al.
CANCER (2012)
Routine TP53 testing for breast cancer under age 30: ready for prime time?
Jeanna M. McCuaig et al.
FAMILIAL CANCER (2012)
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients
Daphne S. C. Lee et al.
BREAST CANCER RESEARCH (2012)
Increased Incidence of Choroid Plexus Carcinoma Due to the Germline TP53 R337H Mutation in Southern Brazil
Gislaine Custodio et al.
PLOS ONE (2011)
Population-Based Estimate of the Contribution of TP53 Mutations to Subgroups of Early-Onset Breast Cancer: Australian Breast Cancer Family Study
Judy Mouchawar et al.
CANCER RESEARCH (2010)
Detailed Haplotype Analysis at the TP53 Locus in p.R337H Mutation Carriers in the Population of Southern Brazil: Evidence for a Founder Effect
Sonia Garritano et al.
HUMAN MUTATION (2010)
2009 Version of the Chompret Criteria for Li Fraumeni Syndrome
Julie Tinat et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Association of the germline TP53 R337H mutation with breast cancer in southern Brazil
Juliana G. Assumpcao et al.
BMC CANCER (2008)
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families
Maria Isabel Waddington Achatz et al.
CANCER LETTERS (2007)
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer
T Walsh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Hereditary cancer predisposition syndromes
JE Garber et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis
S Kato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma
RC Ribeiro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
